# SBB · System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/productcode/SBB

## Overview

- **Product Code:** SBB
- **Device Name:** System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)

## Identification

The colorectal neoplasia RNA and hemoglobin assay is a non-invasive, qualitative in vitro diagnostic intended for the detection of colorectal neoplasia associated RNA markers and for the presence of occult hemoglobin in human stool.  The test is to aid in the detection of colorectal cancer (CRC) and advanced adenomas (AA).  The test is not a replacement for diagnostic colonoscopy.  It is indicated for use in adults 45 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening.  A positive result may indicate the presence of CRC or AA and should be followed by a diagnostic colonoscopy.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P230001](/device/P230001.md) | ColoSense® | Geneoscopy, Inc. | May 3, 2024 | APPR |

## Top Applicants

- Geneoscopy, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/productcode/SBB](https://fda.innolitics.com/productcode/SBB)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com